Los fundamentos de Omnicell Inc son relativamente muy saludable,y su potencial de crecimiento es alto.Su valoración está considerada valorada de forma justa, ranking 27 de 204 en la industria de Equipamiento y suministros sanitarios.Su propiedad institucional es muy alto.Durante el último mes, varios analistas lo han calificado como Compra, con el precio objetivo más alto en 61.29.A medio plazo, se espera que el precio de la acción tienda al alza.Pese a su rendimiento medio en bolsa durante el mes pasado, la empresa muestra unos fundamentos y unos datos técnicos sólidos.Las acciones se mantienen sin una tendencia clara entre los niveles de soporte y resistencia, así que son adecuadas para el swing trading en un mercado lateral.
Puntuación de Omnicell Inc
Información Relacionada
Ranking de la industria
27 / 204
Clasificación general
95 / 4564
Industria
Equipamiento y suministros sanitarios
Resistencia y Soporte
La empresa aún no ha revelado los datos relevantes.
Gráfico de radar
Precio actual
Anterior
Cobertura mediática
Últimas 24 horas
Nivel de cobertura
Muy bajo
Muy alto
Positivo
Aspectos destacados de Omnicell Inc
Puntos fuertesRiesgo
Omnicell, Inc. is a provider of medication management solutions and adherence tools for health systems and pharmacies. The Company is focused on transforming pharmacy care through outcomes-centric innovation designed to optimize clinical and business outcomes across all settings of care through a portfolio of robotics, smart devices, intelligent software, and services. Its point of care automation solutions is designed to improve clinician workflows in patient care areas of the healthcare system, such as nursing units, patient wards, operating rooms, and emergency departments. The Company’s XT Series automated dispensing systems for medications and supplies, which are used in nursing units and other clinical areas of the hospital, are designed to support workflows specific to each area of the hospital, with various software and hardware options. For the operating room, the Company also offer specialized automated dispensing systems.
Sobrevalorada
El PE más reciente de la empresa es 94.02, en un rango percentil alto de 3 años.
Venta institucional
Las tenencias institucionales más recientes son 54.18M acciones, lo que supone una reducción del 0.38% con respecto al trimestre anterior.
Omnicell, Inc. is a provider of medication management solutions and adherence tools for health systems and pharmacies. The Company is focused on transforming pharmacy care through outcomes-centric innovation designed to optimize clinical and business outcomes across all settings of care through a portfolio of robotics, smart devices, intelligent software, and services. Its point of care automation solutions is designed to improve clinician workflows in patient care areas of the healthcare system, such as nursing units, patient wards, operating rooms, and emergency departments. The Company’s XT Series automated dispensing systems for medications and supplies, which are used in nursing units and other clinical areas of the hospital, are designed to support workflows specific to each area of the hospital, with various software and hardware options. For the operating room, the Company also offer specialized automated dispensing systems.